COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1154: Articles 11531-11540  | Next

Appearance of IgG to SARS-CoV-2 in saliva effectively indicates seroconversion in mRNA vaccinated immunocompromised individuals
Healy, K., Pin, E., Chen, P., Soderdahl, G., Nowak, P., Mielke, S., Hansson, L., Bergman, P., Smith, E., Ljungman, P., Valentini, D., Blennow, O., Osterborg, A., Gabarrini, G., Almanei, K., Alkharaan, H., Sobkowiak, M., Xu, X., Akbar, M., Lore, K., Hellstrom, C., Muschiol, S., Bogdanovic, G., Buggert, M., Ljunggren, H.-G., Hober, S., Nilsson, P., Sallberg Chen, M.
10.1101/2021.09.30.21264377 — Posted: 2021-10-03
Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
Dhochak, N., Agrawal, T., Shaman, H., Khan, N. A., Kumar, P., Kabra, S. K., Medigeshi, G. R., Lodha, R.
10.1101/2021.10.01.21264349 — Posted: 2021-10-03
Genomic diversity of SARS-CoV-2 in Pakistan during fourth wave of pandemic
Umair, M., Ikram, A., Rehman, Z., Haider, A., Badar, N., Ammar, M., Ahad, A., Suleman, R., Salman, M.
10.1101/2021.09.30.21264343 — Posted: 2021-10-03
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
Lau, C. L., Mayfield, H. J., Sinclair, J. E., Brown, S. J., Waller, M., Enjeti, A. K., Baird, A., Short, K. R., Mengersen, K., Litt, J.
10.1101/2021.09.30.21264337 — Posted: 2021-10-03
Development and validation of a questionnaire to measure attitudes toward COVID-19 vaccination and pandemic
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Moisoglou, I., Kaitelidou, D.
10.1101/2021.09.30.21264344 — Posted: 2021-10-03
The importance of the population age-structure: insights from Covid-19 dynamics model structured by age, time since infection and acquired immunity
Reyne, B., Richard, Q., Nous, C., Selinger, C., Sofonea, M. T., Djidjou-Demasse, R., Alizon, S.
10.1101/2021.09.30.21264339 — Posted: 2021-10-03
Longitudinal changes and key determinants of meeting WHO recommended levels of physical activity during the COVID-19 pandemic in a UK-based sample: Findings from the HEBECO Study.
Mitchell, J. J., Dicken, S. J., Kale, D., Herbec, A., Beard, E., Shahab, L.
10.1101/2021.09.30.21264358 — Posted: 2021-10-03
COVID-19 risk factors amongst 14,786 care home residents: An observational longitudinal analysis including daily community positive test rates of COVID-19, hospital stays, and vaccination status in Wales (UK) between 1st September 2020 and 1st May 2021.
Hollinghurst, J., Hollinghurst, R., North, L., Mizen, A., Akbari, A., Long, S., Lyons, R. A., Fry, R.
10.1101/2021.09.30.21264338 — Posted: 2021-10-03
COVID-19 mortality in Italy varies by patient age, sex and pandemic wave
Minnai, F., De Bellis, G., Dragani, T. A., Colombo, F.
10.1101/2021.10.01.21264359 — Posted: 2021-10-02 Discussion: Onsite
COVID-19 in twins: What can we learn from them
Castro, M. V., Silva, M. V. R., Naslavsky, M. S., Santos, K. S., Magawa, J. Y., Cunha-Neto, E., Passos Bueno, M. R., Zatz, M.
10.1101/2021.09.29.21263145 — Posted: 2021-10-02 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).